Find a Condition by Name
Health & Wellness Information
Find a Doctor by Name
Departments & Divisions
Locations & Maps
Forms & Medical Records
Travel & Lodging
Becoming a Patient
Patient Safety & Care
Health & Wellness Tips
Patient Education & Support
Professional Education - CME/CE
Adult Clinical Trials
Pediatric Clinical Trials
See All Trials
Core Labs & Diagnostics
Tucker Medical Library
Gifts of Assets
Since the introduction of effective chemotherapy, many changes have come about in the management of tuberculosis (TB). Most important have been the shift from sanatoria-based to general hospital and clinic-based treatment and the knowledge that active disease can reliably be prevented among those who are latently infected. With the development of effective drugs for TB, the significant advances in bacteriology, and increased knowledge about the treatment of latent TB infection, the approach to tuberculosis control has become increasingly sophisticated.
The 57th Annual Denver TB Course (Online Series) provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis.
Epidemiology of tuberculosis
Transmission and pathogenesis
Diagnosis and treatment of tuberculosis including MDR/XDR-TB
Diagnosis and treatment of latent tuberculosis infection
Emphasis on vulnerable populations such as pediatric and HIV co-infection
Interactive Contact Investigation Workshop
Discuss the epidemiological features which are associated with increased risk for tuberculosis.
Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection.
Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings.
Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the pharmacokinetics and potential toxicities of that regimen.
Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB.
The 57th Annual TB Course followed a new format in 2021 with weekly virtual presentations being led by expert faculty from April 2 – May 7, 2021. All recorded sessions are now available for purchase and CME/CNE credit through October 31, 2021.
Randall Reves, MD
Professor, Infectious Diseases and Epidemiology
University of Colorado Denver School of Medicine
University of Colorado School of Public Health
The following fees include access to all of the recordings of the live sessions through October 31, 2021, as well as CME/CNE credit for courses viewed.
$135 Military, Fellow and Resident*
$50 National Jewish Health Staff
* Verification of Fellowship Status Form (required)
To pay now, please fill out the registration form below. To make payment arrangements, please contact ProEd@njhealth.org.
If you are having problems registering, please call 800.844.2305 or 303.398.1000 or email email@example.com.
Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
National Jewish Health designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 7.25 contact hours.
Registered nurses will receive a separate certificate for each session of the course. You must view the full session to earn credit; partial credit will not be awarded.